Remove Communication Remove FDA Remove Patient Care
article thumbnail

How the US’s pending PIE Act will improve patient access to medication

pharmaphorum

Jennifer Mathieu, director of government relations at the Academy of Managed Care Pharmacy (AMCP), tells us why the organisation backed the pre-approval information exchange (PIE) Act of 2022 and how the legislation will empower companies to share information with healthcare payers and plans during the FDA approval process. .

FDA 95
article thumbnail

Clinical research in 2021: A new era of collaboration and innovation

pharmaphorum

That said, while industry is already scrutinised from within, increased public pressure for transparency will require all clinical trial experts (including regulators) to communicate proactively with the public. Fortunately, many of the issues in this space are due to very fixable communication deficiencies.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Digital therapeutics and healthcare innovation

pharmaphorum

Digital technology is transforming the way that healthcare is practiced and delivered, with areas like digital therapeutics forging ahead to complement traditional medical approaches and augment patient care. We’ll be looking at how digital and traditional approaches to medicine are being combined to improve patient outcomes.

article thumbnail

Study finds unexpected prescription influencers in healthcare

pharmaphorum

“So many more drugs are coming to market, and if you look at what the FDA has done over the last five years with approvals versus the actual pool of individuals to speak with, there’s a vast change in the need and the demand,” Lapolla states. Influential individuals. “It’s about digging deeper. .

article thumbnail

Complete guide on pharmaceutical medical affairs

Viseven

Medical affairs in Pharma are often seen as a central agency that works within a healthcare company and prioritize communication among life science organizations, medical professionals, healthcare providers, and patients. Medical affairs definition uses clinical and scientific information to communicate the efficiency of a drug.

article thumbnail

Amplifying the patient voice for better engagement, recruitment and retention

pharmaphorum

For this reason alone, it’s important to see them as partners and collaborators in the process of drug development, rather than them being the ‘necessary evil’ that maybe characterised some previous approaches to patient care during trials. About Prime Global.

article thumbnail

Patient Engagement in Pharma – Why and How?

Viseven

Leading companies are now investing heavily in patient engagement training, signaling a big shift in industry priorities. This change is further driven by major regulatory bodies emphasizing Patient-Focused Drug Development (PFDD). This education can be delivered through various formats, such as webinars, videos, and written materials.